Nicotine-free fluid alternative to conventional NRT products is now available in the U.S., Rosen Holdings announces Nov. 19. Product has been available in the UK, Ireland, New Zealand and Australia. NicoBloc "is a clinically proven" smoking reduction method that slowly alleviates smokers' nicotine addiction "by blocking the tar and nicotine inhaled and [letting] them quit at their own pace." Smokers using the three-stage, six-week NicoBloc program drop the fluid on cigarettes to trap tar and nicotine; one drop traps 33% of the harmful substances, according to Rosen. Smokers may choose to be "smoke-free in as little as" one week, since consumers can set their own quitting pace, the Plymouth, Mass.-based firm maintains. NicoBloc bottles contain enough fluid for one pack of cigarettes. The product retails for $39.99 at Eckerd and online at drugstore.com...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
Kumar takes over as acting director of the Center for Biologics Evaluation and Research’s Office of Therapeutic Products days after director Nicole Verdun was ousted.